Korea’s 7 botanical drugs developed under Pharmaceutical Affairs Law: KPMA

The Korea Pharmaceutical Manufacturers Association (KPMA) said Wednesday that the nation’s 7 botanical drugs, including Dong-A’s Stillen and SK Chemicals’ Joins, are prescription drugs developed through a series of clinical trials in accordance with the provisions of the Pharmaceutical Affairs Law, dismissing the claims by the oriental medicine circle that the approval of these natural products...